The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Abstract
INTRODUCTION: The RAS/RAF/MAP kinase-ERK kinase (MEK)/extracellular-signal-regulated kinase (ERK) (MAPK) and the PI3K/AKT/mammalian target of rapamycin (mTOR) (PI3K) pathways are frequently deregulated in human cancer as a result of genetic alterations in their components or upstream activation of cell-surface receptors. These signalling cascades are regulated by complex feedback and cross-talk mechanisms. AREAS COVERED: In this review the key components of the MAPK and AKT pathways and their molecular alterations are described. The complex interactions between these signalling cascades are also analysed. EXPERT OPINION: The observation that the MAPK and the PI3K pathways are often deregulated in human cancer…
Citation impact
- FWCI
- 25.26
- Percentile
- 100%
- References
- 65
Authors
5- ADAntonella De LucaCorresponding
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
- MRMonica R. Maiello
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
- ADAmelia D’Alessio
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
- MPMaria Pergameno
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
- NNNicola Normanno
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Topics & keywords
- PI3K/AKT/mTOR pathway
- MAPK/ERK pathway
- Protein kinase B
- Signal transduction
- Kinase
- Biology
- Cancer research
- Cell biology
- Good health and well-being